| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 32.84B | 32.53B | 26.78B | 33.22B | 27.38B | 19.01B |
| Gross Profit | 10.93B | 25.06B | 20.67B | 19.41B | 14.54B | 9.38B |
| EBITDA | 20.54B | 21.33B | 18.11B | 18.68B | 16.10B | 10.90B |
| Net Income | 10.81B | 10.00B | 8.61B | 9.54B | 9.01B | 6.00B |
Balance Sheet | ||||||
| Total Assets | 100.52B | 88.14B | 81.65B | 67.44B | 60.51B | 55.32B |
| Cash, Cash Equivalents and Short-Term Investments | 23.19B | 10.45B | 13.47B | 10.06B | 12.37B | 13.33B |
| Total Debt | 0.00 | 46.66B | 48.03B | 40.62B | 34.41B | 27.92B |
| Total Liabilities | 72.32B | 63.30B | 57.03B | 46.50B | 40.68B | 34.89B |
| Stockholders Equity | 25.70B | 22.47B | 22.35B | 19.78B | 18.64B | 19.29B |
Cash Flow | ||||||
| Free Cash Flow | 8.90B | 5.85B | 8.83B | 3.49B | 4.09B | 6.15B |
| Operating Cash Flow | 21.35B | 18.25B | 16.67B | 13.93B | 12.52B | 11.10B |
| Investing Cash Flow | -12.45B | -12.27B | -8.78B | -11.09B | -8.48B | -4.97B |
| Financing Cash Flow | -2.45B | -9.43B | -5.02B | -4.79B | -4.93B | -7.35B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | $5.64B | 19.42 | 52.26% | 4.03% | 1.10% | 3.23% | |
73 Outperform | $13.55B | 16.88 | 58.94% | 4.46% | 20.39% | 16.34% | |
69 Neutral | $4.08B | 17.03 | 17.03% | ― | 12.89% | -1.83% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
61 Neutral | $9.56B | 15.78 | 31.24% | 11.85% | 18.61% | -27.53% |